Przejdź do zawartości
Merck

11836153001

Roche

cOmplete, Mini Protease Inhibitor Cocktail

Tablets provided in a glass vial

Synonim(y):

Protease inhibitor

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
12352204

Postać

tablet

zastosowanie

sufficient for 25 10mL extraction solution preparations

opakowanie

vial of 25 tablets

producent / nazwa handlowa

Roche

metody

tissue processing: suitable

rozpuszczalność

water: soluble

temp. przechowywania

2-8°C

Opis ogólny

cOmplete, Mini Protease Inhibitor Tablets, inhibit a broad spectrum of serine, cysteine, and metalloproteases, as well as calpains.
Due to the optimized composition of the tablets, they show excellent inhibition effects, and are well suited for the protection of proteins isolated from animal tissues, plants, yeast, and bacteria.
cOmplete, Mini Protease Inhibitor Tablets contain EDTA and both irreversible and reversible protease inhibitors.

Specyficzność

For the inhibition of serine, cysteine, and metalloproteases in bacterial, mammalian, yeast, and plant cell extracts.

Zastosowanie

cOmplete, Mini Protease Inhibitor Cocktail has been used as a
component of
  • lysis buffer for lysing glioma tumor samples
  • radioimmunoprecipitation (RIPA) protein extraction buffer for homogenization of heart tissues
  • resuspension buffer for retinal ganglion cells homogenization

cOmplete, Mini, is used for the inhibition of serine, cysteine, and metalloproteases in bacterial, mammalian, yeast, and plant cell extracts.
cOmplete, Mini, contains both reversible and irreversible protease inhibitors. Therefore, we recommend the addition of cOmplete, Mini, to all stock buffers and solutions normally protected with protease inhibitors, and not  just during the initial purification steps.
cOmplete, Mini contains EDTA (1 tablet yields a  1 mM EDTA solution  in 10 ml). Therefore, the extraction buffer should not contain divalent cations like Ca2+, Mg2+, or Mn2+, otherwise the inhibition of the metalloproteases might be incomplete. If the protein of interest will be purified by IMAC (Immobilized Metal  Affinity Chromatography), for example, Poly-His-tagged recombinant proteins, EDTA has to be eliminated (e.g., by dialysis) prior to the chromatography.
Alternatively, the product cOmplete, Mini EDTA-free, can be used. These tablets are identical to cOmplete, Mini, with the exception that no EDTA or other chelating agent is  present.
cOmplete, Mini Tablets, inhibit proteolytic activity in small extraction volumes (up to 10 ml). If you are working with a larger volume (up to 50 ml) we recommend to use a different cOmplete product. The composition of the cOmplete Tablet is identical to the cOmplete, Mini Tablet, therefore comparable results are achieved with both product types.

Cechy i korzyści

Use cOmplete, Mini Protease Inhibitor Tablets to protect your proteins from a wide range of proteases. In just minutes, uninhibited proteolytic activity can degrade the protein you have spent days isolating. Each of these convenient water-soluble tablets contains a blend of protease inhibitors that inhibits proteolytic activity from most cell types, including animals, plants, yeast, and bacteria. No weighing or measuring is necessary, ensuring consistent results.

  • Easy-to-use: Simply drop a quick-dissolving tablet into your buffer.
  • Complete protection: Instantly protect your proteins against a broad range of proteases.
  • Flexible: Protect proteins in extracts from almost any tissue or cell, including animals, plants, yeast, bacteria, or fungi.
  • Safe: Choose non-toxic inhibitors that pose no risk to you or those around you.
  • Suitable for IMAC purification: Purify poly-histidine tagged proteins with cOmplete His-Tag Purification Resin.

Opakowanie

Ships on Wet Ice in some cases however, shipping conditions may vary in certain regions.

Komponenty

Proprietary mixture of several protease inhibitors with broad inhibitory specificity.

Jakość

Performance-tested with pancreas extract.

Postać fizyczna

Tablets in glass vials

Uwaga dotycząca przygotowania

Working concentration: 1 tablet per 10 ml extraction solution
Working solution: Preparation of Working Solution

One cOmplete Mini Protease Inhibitor Tablet is sufficient for the inhibition of the proteolytic activity in 10 ml extraction solution. When very high proteolytic activity is present, one tablet should be used for 7 ml extraction buffer. Tablets can be added directly to the extraction medium. Alternatively, a stock solution (7 X conc.) can be prepared.

Stock solution (7 X conc.)

Dissolve one cOmplete Mini tablet in 1.5 ml dist. water or in 1.5 ml 100 mM phosphate buffer, pH 7.0.
Storage conditions (working solution): The stock solution can be stored at 2 to 8 °C for 1 to 2 weeks, or at least 12 weeks at -15 to -25 °C.

Rekonstytucja

Soluble in aqueous buffers, or add directly to extraction media. Alternatively, prepare 7x stock solutions in 1.5 ml water or 100 mM phosphate buffer, pH 7.0. Stock solution is stable for 1-2 weeks at 2 to 8 °C or at least 12 weeks at -15 to -25 °C; can be used in thiol-containing solutions at 15 to 25 °C.

Informacje prawne

cOmplete is a trademark of Roche
This page may contain text that has been machine translated.

Piktogramy

Exclamation mark

Hasło ostrzegawcze

Warning

Zwroty wskazujące rodzaj zagrożenia

Klasyfikacja zagrożeń

Eye Irrit. 2 - Skin Irrit. 2

Kod klasy składowania

11 - Combustible Solids

Klasa zagrożenia wodnego (WGK)

WGK 2

Temperatura zapłonu (°F)

does not flash

Temperatura zapłonu (°C)

does not flash


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Paloma Araujo Cavalcante et al.
Infection and immunity, 88(7) (2020-04-29)
Staphylococcus aureus, an important cause of mastitis in mammals, is becoming increasingly problematic due to the development of resistance to conventional antibiotics. The ability of S. aureus to invade host cells is key to its propensity to evade immune defense
Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma
Dettling S, et al.
Clinical Cancer Research, 24(12), 2951-2962 (2018)
Ang Li et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 28(6), 1432-1441 (2020-04-30)
Adeno-associated viral (AAV) vectors are a leading candidate for the delivery of CRISPR-Cas9 for therapeutic genome editing in vivo. However, AAV-based delivery involves persistent expression of the Cas9 nuclease, a bacterial protein. Recent studies indicate a high prevalence of neutralizing antibodies
Essential role for smooth muscle cell stromal interaction molecule-1 in myocardial infarction.
Mali V, et al.
Journal of Hypertension, 36(2), 377-386 (2018)
The N-terminal set-beta protein isoform induces neuronal death
Trakhtenberg EF, et al.
The Journal of biological chemistry, 290(21), 13417-13426 (2015)

Produkty

Koktajle z inhibitorami proteaz utrzymują i zachowują skład białek komórkowych po lizie komórek. W przypadku stosowania z CelLytics, zachowują one również aktywność białka docelowego. Koktajle te zostały zoptymalizowane pod kątem szerokiej gamy konkretnych zastosowań, zapewniając doskonałą inhibicję i łatwość użycia.

Get maximum protection after protein isolation by using protease and phosphatase inhibitor cocktail tablets from Roche.

Powiązane treści

Wybierz różne typy inhibitorów proteaz w zależności od potrzeb, aby zapobiec degradacji białek podczas izolacji i charakteryzacji oraz zabezpieczyć białka podczas przygotowywania próbek.

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej